INFUSYSTEM HOLDINGS, INC Federal Income Tax Expense (Benefit), Continuing Operations
INFUSYSTEM HOLDINGS, INC (INFU) reported Federal Income Tax Expense (Benefit), Continuing Operations of $2.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-27
- INFUSYSTEM HOLDINGS, INC federal income tax expense (benefit), continuing operations for fiscal 2025 was $2.50M, a 49.49% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC federal income tax expense (benefit), continuing operations for fiscal 2024 was $1.67M, a 194.54% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC federal income tax expense (benefit), continuing operations for fiscal 2023 was $568.00K.
- INFUSYSTEM HOLDINGS, INC federal income tax expense (benefit), continuing operations for fiscal 2022 was -$44.00K.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month | Federal Income Tax Expense (Benefit), Continuing Operations 12 month as first filed |
|---|---|---|
| 2025-12-31 | $2.50M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $1.67M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $568.00K 10-K · filed 2025-03-11 | |
| 2022-12-31 | -$44.00K 10-K · filed 2024-04-10 | |
| 2021-12-31 | -$150.00K 10-K · filed 2024-04-10 | |
| 2020-12-31 | -$8.34M 10-K · filed 2023-03-16 | |
| 2019-12-31 | $104.00K 10-K · filed 2022-03-15 | |
| 2018-12-31 | -$62.00K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $13.76M 10-K · filed 2019-03-22 | |
| 2016-12-31 | -$157.00K 10-K · filed 2018-03-19 | |
| 2015-12-31 | $970.00K 10-K · filed 2017-03-22 | $1.51M 10-K · filed 2016-03-09 |
| 2014-12-31 | $2.30M 10-K/A · filed 2016-12-12 | |
| 2013-12-31 | $1.11M 10-K · filed 2015-03-09 | |
| 2012-12-31 | -$810.00K 10-K · filed 2014-03-11 | |
| 2011-12-31 | -$21.25M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |